Araujo, John C. Trudel, Geralyn C. Saad, Fred Armstrong, Andrew J. Yu, Evan Y. Bellmunt, Joaquim Wilding, George and McCaffrey, John Serrano, Sergio V. Matveev, Vsevolod and Efstathiou, Eleni Oudard, Stephane Morris, Michael J. Sizer, Bruce Goebell, Peter J. De Bono, Johann Sebastian Paliwal, Prashni Durham, Susan Cheng, Shinta Logothetis, Christopher, Overall survival (OS) and safety of dasatinib/docetaxel versus docetaxel
in patients with metastatic castration-resistant prostate cancer
(mCRPC): Results from the randomized phase III READY trial, World Journal of Clinical Oncology, (31), 2013, AMER SOC CLINICAL ONCOLOGY 2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA,